Memorial Page for Paul Berg

Paul Berg (born 30 June 1926 in New York City; died 15 February 2023 in Stanford, California) was an American biochemist. He is one of the central figures of molecular biology because his work on recombinant DNA showed that genetic material from different organisms could be deliberately joined. In 1980 he received half of the Nobel Prize in Chemistry. Berg stands not only for a technical breakthrough, but also for the early question of how research should handle new biological possibilities responsibly.

Education and Stanford

Berg grew up in New York and developed an early interest in experimental science. After service in the U.S. Navy, he studied at Pennsylvania State University and earned his doctorate at Western Reserve University. Further research positions took him to Copenhagen and to Washington University in St. Louis. In 1959 he joined the Stanford University School of Medicine, where he spent decades researching, teaching and helping shape the development of biochemistry.

Recombinant DNA

His scientific breakthrough grew out of the question of how genes could be isolated, joined and studied in cells. In work with the tumor virus SV40, Berg's group succeeded in 1972 in inserting bacterial DNA into viral DNA. Such molecules became known as hybrid or recombinant DNA. This work opened a new approach to biology: genes could no longer only be observed, but deliberately combined and studied in their function.

Opportunity and responsibility

Berg saw early that the new technique created not only possibilities, but also risks and social questions. In the mid-1970s he was among the researchers who called for a cautious pause and clear safety rules for certain experiments. From 24 to 27 February 1975, scientists, lawyers and other experts met at Asilomar in California. The conference became an important example of a research community developing standards before a technology was widely used.

Nobel Prize

On 14 October 1980 the Royal Swedish Academy of Sciences announced that Paul Berg would receive half of the Nobel Prize in Chemistry. He was honored for fundamental studies of the biochemistry of nucleic acids, especially in relation to recombinant DNA. The other half of the prize was shared by Walter Gilbert and Frederick Sanger for work on determining base sequences. Together, the award marked a moment when modern gene research and DNA technology moved visibly into the center of chemistry and biology.

Later years and legacy

After the Nobel Prize, Berg remained active at Stanford and continued to engage with science education, research policy and the responsible use of biomedical technologies. He died on the Stanford University campus on 15 February 2023. His importance lies in two closely connected achievements: he helped create the tools of genetic engineering, and he took seriously the question of what rules such tools require. That made Paul Berg a key figure for molecular biology, biotechnology and scientific responsibility.